| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| ATRS | ANTARES PHARMA, INC. | EVP, Research and Development and Chief Medical Officer | May 24, 2022 | |||
| NONE | Mallinckrodt plc | EVP & Chief Scientific Officer | Feb 2, 2024 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|